Development of Complementary Encounter and Patient Decision Aids for Shared Decision Making about Stroke Prevention in Atrial Fibrillation.

IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES
MDM Policy and Practice Pub Date : 2023-06-21 eCollection Date: 2023-01-01 DOI:10.1177/23814683231178033
Aubrey E Jones, Madeleine M McCarty, Kenzie A Cameron, Kerri L Cavanaugh, Benjamin A Steinberg, Rod Passman, Preeti Kansal, Adriana Guzman, Emily Chen, Lingzi Zhong, Angela Fagerlin, Ian Hargraves, Victor M Montori, Juan P Brito, Peter A Noseworthy, Elissa M Ozanne
{"title":"Development of Complementary Encounter and Patient Decision Aids for Shared Decision Making about Stroke Prevention in Atrial Fibrillation.","authors":"Aubrey E Jones, Madeleine M McCarty, Kenzie A Cameron, Kerri L Cavanaugh, Benjamin A Steinberg, Rod Passman, Preeti Kansal, Adriana Guzman, Emily Chen, Lingzi Zhong, Angela Fagerlin, Ian Hargraves, Victor M Montori, Juan P Brito, Peter A Noseworthy, Elissa M Ozanne","doi":"10.1177/23814683231178033","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Decision aids (DAs) are helpful instruments used to support shared decision making (SDM). Patients with atrial fibrillation (AF) face complex decisions regarding stroke prevention strategies. While a few DAs have been made for AF stroke prevention, an encounter DA (EDA) and patient DA (PDA) have not been created to be used in conjunction with each other before.</p><p><strong>Design: </strong>Using iterative user-centered design, we developed 2 DAs for anticoagulation choice and stroke prevention in AF. Prototypes were created, and we elicited feedback from patients and experts via observations of encounters, usability testing, and semistructured interviews.</p><p><strong>Results: </strong>User testing was done with 33 experts (in AF and SDM) and 51 patients from 6 institutions. The EDA and PDA underwent 1 and 4 major iterations, respectively. Major differences between the DAs included AF pathophysiology and a preparation to meet with the clinician in the PDA as well as different language throughout. Content areas included personalized stroke risk, differences between anticoagulants, and risks of bleeding. Based on user feedback, developers 1) addressed feelings of isolation with AF, 2) improved navigation options, 3) modified content and flow for users new to AF and those experienced with AF, 4) updated stroke risk pictographs, and 5) added structure to the preparation for decision making in the PDA.</p><p><strong>Limitations: </strong>These DAs focus only on anticoagulation for stroke prevention and are online, which may limit participation for those less comfortable with technology.</p><p><strong>Conclusions: </strong>Designing complementary DAs for use in tandem or separately is a new method to support SDM between patients and clinicians. Extensive user testing is essential to creating high-quality tools that best meet the needs of those using them.</p><p><strong>Highlights: </strong>First-time complementary encounter and patient decision aids have been designed to work together or separately.User feedback led to greater structure and different experiences for patients naïve or experienced with anticoagulants in patient decision aids.Online tools allow for easier dissemination, use in telehealth visits, and updating as new evidence comes out.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"8 1","pages":"23814683231178033"},"PeriodicalIF":1.9000,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10765759/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MDM Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23814683231178033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Decision aids (DAs) are helpful instruments used to support shared decision making (SDM). Patients with atrial fibrillation (AF) face complex decisions regarding stroke prevention strategies. While a few DAs have been made for AF stroke prevention, an encounter DA (EDA) and patient DA (PDA) have not been created to be used in conjunction with each other before.

Design: Using iterative user-centered design, we developed 2 DAs for anticoagulation choice and stroke prevention in AF. Prototypes were created, and we elicited feedback from patients and experts via observations of encounters, usability testing, and semistructured interviews.

Results: User testing was done with 33 experts (in AF and SDM) and 51 patients from 6 institutions. The EDA and PDA underwent 1 and 4 major iterations, respectively. Major differences between the DAs included AF pathophysiology and a preparation to meet with the clinician in the PDA as well as different language throughout. Content areas included personalized stroke risk, differences between anticoagulants, and risks of bleeding. Based on user feedback, developers 1) addressed feelings of isolation with AF, 2) improved navigation options, 3) modified content and flow for users new to AF and those experienced with AF, 4) updated stroke risk pictographs, and 5) added structure to the preparation for decision making in the PDA.

Limitations: These DAs focus only on anticoagulation for stroke prevention and are online, which may limit participation for those less comfortable with technology.

Conclusions: Designing complementary DAs for use in tandem or separately is a new method to support SDM between patients and clinicians. Extensive user testing is essential to creating high-quality tools that best meet the needs of those using them.

Highlights: First-time complementary encounter and patient decision aids have been designed to work together or separately.User feedback led to greater structure and different experiences for patients naïve or experienced with anticoagulants in patient decision aids.Online tools allow for easier dissemination, use in telehealth visits, and updating as new evidence comes out.

房颤卒中预防共同决策的互补遭遇和患者决策辅助的发展
决策辅助工具(DAs)是用于支持共享决策(SDM)的有用工具。心房颤动(AF)患者在卒中预防策略方面面临复杂的决策。虽然已有一些DAs用于预防房颤,但在此之前还没有创建过相遇DA (EDA)和患者DA (PDA)来相互结合使用。采用迭代的以用户为中心的设计,我们开发了2个用于房颤抗凝选择和卒中预防的DAs。我们创建了原型,并通过观察遭遇、可用性测试和半结构化访谈从患者和专家那里获得反馈。结果对来自6家机构的33名AF和SDM专家和51名患者进行了用户测试。EDA和PDA分别经历了1次和4次主要迭代。两组患者之间的主要差异包括房颤病理生理、与临床医生会面的准备以及不同的语言。内容领域包括个体化中风风险、抗凝剂之间的差异和出血风险。根据用户反馈,开发人员1)解决了AF的孤立感,2)改进了导航选项,3)为AF新手和AF经验丰富的用户修改了内容和流程,4)更新了中风风险象形图,5)为PDA中的决策准备增加了结构。这些DAs只关注用于预防中风的抗凝治疗,并且是在线的,这可能会限制那些对技术不太熟悉的人的参与。结论设计辅助DAs串联或单独使用是支持患者和临床医生之间SDM的新方法。广泛的用户测试对于创建最能满足使用者需求的高质量工具是必不可少的。第一次互补性接触和患者决策辅助被设计为一起或单独工作。用户反馈为患者带来了更大的结构和不同的体验naïve或有抗凝血剂经验的患者决策辅助。在线工具可以更容易地传播、在远程保健访问中使用,并随着新证据的出现而更新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
MDM Policy and Practice
MDM Policy and Practice Medicine-Health Policy
CiteScore
2.50
自引率
0.00%
发文量
28
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信